View Older Stories View More Recent Stories

Dec 19, 2024 08:30AM PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis
Dec 19, 2024 08:30AM Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
Dec 19, 2024 08:30AM One of the World's Largest Semiconductor Manufacturers Renews Its Contract with Ondas' Airobotics for Drone Aerial Security and Data Services
Dec 19, 2024 08:30AM HYCU® Unveils Significant Updates to HYCU R-Cloud™ That Provide Seamless Data Mobility Across Clouds and Hypervisors
Dec 19, 2024 08:15AM Richtech Robotics to Showcase Latest Service Robotics Innovations at CES 2025, Featuring AI-Driven Scorpion Robot and New Delivery Robots
Dec 19, 2024 08:15AM Plus3 IT Systems Awarded as Subcontractor for DLA JETS 2.0
Dec 19, 2024 08:13AM SWA Lithium Advances and Derisks DLE Technology with Field-Testing at South West Arkansas Lithium Project
Dec 19, 2024 08:05AM MARA (MARA) reports BTC Yield of 60.9%
Dec 19, 2024 08:03AM Soluna Holdings (SLNH) Appoints Ernest Popescu to its Board
Dec 19, 2024 08:03AM Mainz Biomed (MYNZ) Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
Dec 19, 2024 08:03AM NV5 Global (NVEE) Awarded $7M in Infrastructure Design Contracts by the City of Philadelphia
Dec 19, 2024 08:01AM Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
Dec 19, 2024 08:01AM Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 19, 2024 08:00AM Ladybug Resource Group Accelerates Strategy and Expands E-Commerce Portfolio With Key Acquisitions
Dec 19, 2024 08:00AM NV5 Awarded $7 Million in Infrastructure Design Contracts by the City of Philadelphia
Dec 19, 2024 08:00AM Gold and Gemstone Mining Achieves Record $8.6 Million Revenue
Dec 19, 2024 08:00AM Golden Matrix Group to Participate in the 2025 ICR Conference
Dec 19, 2024 08:00AM Clene Improves Cash Position and Runway by Securing New Debt Facility to Pay Off Existing Senior Loan
Dec 19, 2024 08:00AM Union Pacific Corporation Announces Fourth Quarter 2024 Earnings Release Date
Dec 19, 2024 08:00AM Soluna Holdings Announces the Appointment of Ernest Popescu to Advisory Board
Dec 19, 2024 08:00AM JumpCloud's G2 Scores Prove Its Leadership in Simplified IT Management
Dec 19, 2024 08:00AM Liberty Star Announces  Assay Results from The Hay Mountain Project Red Rock Canyon MEP Area Containing Bonanza Grade Gold Results
Dec 19, 2024 08:00AM Playa Bowls Chooses Qu to Support Rapid Growth and Streamline Operations Across Its Expanding Network of Locations
Dec 19, 2024 08:00AM Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
Dec 19, 2024 08:00AM American Oncology Network’s Specialty Pharmacy Achieves ACHC Reaccreditation
Dec 19, 2024 08:00AM Gold and Gemstone Mining Achieves Record $8.6 Million Revenue
Dec 19, 2024 08:00AM Golden Matrix Group to Participate in the 2025 ICR Conference
Dec 19, 2024 08:00AM Ladybug Resource Group Accelerates Strategy and Expands E-Commerce Portfolio With Key Acquisitions
Dec 19, 2024 08:00AM CES UNVEILED NEWS: EXPLORE 10 SWISSTECH COMPANIES AT CES UNVEILED
Dec 19, 2024 08:00AM Onxy Gold Corp Recaps 2024 Exploration Work
Dec 19, 2024 07:31AM NLS Pharmaceutics (NLSP) and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance for FDA Pre-IND Meeting
Dec 19, 2024 07:31AM Palatin Technologies (PTN) Announces Positive Phase IIb BREAKOUT Study Results
Dec 19, 2024 07:30AM Altimmune (ALT) Added to Nasdaq Biotechnology Index
Dec 19, 2024 07:30AM Pudu Robotics Unveils PUDU D9: A Full-Sized Humanoid Robot Driving Commercially Viable Embodied Intelligence
Dec 19, 2024 07:30AM Altimmune Added to Nasdaq Biotechnology Index
Dec 19, 2024 07:30AM Realbotix Shares 2025 Outlook
Dec 19, 2024 07:30AM NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND Meeting for an Innovative Breakthrough Type 1 Diabetes Treatment
Dec 19, 2024 07:30AM Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 19, 2024 07:30AM Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy
Dec 19, 2024 07:17AM Blackline Safety Announces Fiscal Fourth Quarter and Year End 2024 Financial Results Conference Call
Dec 19, 2024 07:14AM El Sapo Pepe $PEPE: The First Pepe That Inspired Matt Furie's Pepe
Dec 19, 2024 07:14AM El Sapo Pepe $PEPE: The First Pepe That Inspired Matt Furie's Pepe
Dec 19, 2024 07:11AM Putin says Google is a tool used by the United States
Dec 19, 2024 07:03AM Bio-Techne (TECH) enters co-marketing and co-promotion agreement with Waters Corporation
Dec 19, 2024 07:00AM Nevada Lithium Announces Conditional Approval of TSX Venture Exchange Uplisting
Dec 19, 2024 07:00AM Gold79 Announces Name Change to West Point Gold; Ticker Symbol Change to "WPG"
Dec 19, 2024 07:00AM BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
Dec 19, 2024 06:50AM Kimco Realty® Invites You to Join Its Fourth Quarter Earnings Conference Call
Dec 19, 2024 06:45AM Merck (MRK) Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir
Dec 19, 2024 06:45AM Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults
View More Recent Stories View Older Stories